ArriVent BioPharma (AVBP) Non-Current Assets (2022 - 2026)
ArriVent BioPharma (AVBP) posted Non-Current Assets of $545,000 for Q2 2026, down 97.2% from $19.36 million a year earlier and down 8.4% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, ArriVent BioPharma's Non-Current Assets came in at $272,000, down 99.4% from FY2024.
- In prior years, ArriVent BioPharma's Non-Current Assets was $47.96 million in FY2024 and $3.13 million in FY2023.
- Quarterly Non-Current Assets has run from a low of $272,000 in Q4 2025 to a high of $47.96 million in Q4 2024 over five years.
- On a year-over-year basis, Non-Current Assets has declined in each of the last three quarters.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $595,000 (Q1 2026), $272,000 (Q4 2025) and $5.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | ArriVent BioPharma | 690.85 Mn | -714.69 Mn | - | 474,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 474,000.00 |
| Jun 30, 2026 | 545,000.00 |
| Mar 31, 2026 | 595,000.00 |
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 19.36 Mn |
| Mar 31, 2025 | 29.71 Mn |
| Dec 31, 2024 | 47.96 Mn |
| Sep 30, 2024 | 313,000.00 |
| Jun 30, 2024 | 344,000.00 |
| Mar 31, 2024 | 358,000.00 |
| Dec 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 211,000.00 |
API Access
ArriVent BioPharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();